Form D Explorer

Inspect source fieldsReport a record issue

Form D — Cyrus Biotechnology, Inc.

0001641241-25-000003 · filed Jul 16, 2025

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Check this disclosure on SEC EDGAR · More Biotechnology filings

Offering

Industry
Biotechnology
Exemptions
Rule 506(b)
Reported offering amount
$1,500,000
Reported amount sold
$1,110,000
Minimum investment
$0
Investors
—
Sales commission
—
Finders' fees
—

Issuer

Name
Cyrus Biotechnology, Inc.
CIK
1641241
Entity
Corporation
Jurisdiction
DELAWARE
Year incorporated
—
Address
3005 1ST AVE
SEATTLE, Washington 98121
Phone
2062586561

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

Other filings from this issuer

View the original filing on SEC EDGAR ↗